To test whether PD-L1 can enter the nucleus of NSCLC cells under the treatment of paclitaxel and cisplatin, cytoplasmic and nuclear fraction of treated cells was isolated and then subjected to western blot analysis. This evidence concerns the gene CD274 and non-small cell lung carcinoma.